BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.563K / 2.555M |
Day Range | - - - |
52 Wk Range | 0.445 - 8.690 |
Market Cap | $26.529M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 4.71% |
Days to Cover | 1.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioVie (NASDAQ: BIVI) through any online brokerage.
Other companies in BioVie’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO), Palatin Techs (AMEX:PTN) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for BioVie (NASDAQ: BIVI) was reported by Oppenheimer on Thursday, November 30, 2023. The analyst firm set a price target for 5.00 expecting BIVI to rise to within 12 months (a possible 935.20% upside). 5 analyst firms have reported ratings in the last year.
The stock price for BioVie (NASDAQ: BIVI) is $0.483 last updated Today at April 25, 2024 at 6:38 AM EDT.
There are no upcoming dividends for BioVie.
BioVie’s Q3 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.